Associate Director
CSL
Associate Director
CSL
Develops and delivers biotherapies and vaccines
The Associate Director, Procurement Enablement of Responsible Procurement, Governance and Talent Development is responsible for strengthening the governance and capability foundations of Enterprise Procurement & Supplier Management (ESPM). Reporting to the Director, Procurement Enablement and working with him and the Supplier Management Leadership team, this role owns three connected agendas for the function: the governance framework —policies, procedures, playbooks, standards, and standard operating procedures (SOPs) — and the compliance reporting behind it; the design, execution, and reporting of the function's Environmental, Social, and Governance (ESG) strategy in partnership with the Corporate governing functions and EPSM’s category and sourcing teams.
The role also leads the design and delivery of EPSM’s talent development framework to develop procurement talent at every level. This includes managing the EPSM’s Talent Strategy, developed in partnership with the Chief Procurement Officer (CPO) and his leadership team, and Human Resources (HR). Once established, the role will assume full accountability of EPSM’s Procurement Academy's day-to-day operation.
This is an individual contributor role that leads through influence rather than direct authority. Acting as a trusted advisor and change leader across ESPM, building strong stakeholder relationships and driving adoption of new processes, tools, and ways of working.
RESPONSIBILITIES AND ACCOUNTABILITIES :
1. Procurement Governance
2. ESG Strategy and Delivery
3. Learning and Development
Leadership Expectations
Other Responsibilities
Education :
Experience:
Competency
Working Conditions:
Travel Requirements:
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
CSL is a global biotechnology company that develops and delivers biotherapies and influenza vaccines. It focuses on plasma-derived and recombinant therapies for rare and serious diseases and sells to healthcare providers, hospitals, and governments across the Americas, Asia Pacific, and Europe. Its product range includes treatments for rare diseases, influenza vaccines, and antivenoms, produced through its R&D, manufacturing, and distribution operations. CSL differentiates itself by offering the broadest portfolio of plasma-derived and recombinant therapies and by leveraging its global footprint and emphasis on diversity to reach diverse markets. The company’s main goal is to save lives and protect health by expanding access to high-quality therapies and vaccines worldwide.
Explore more opportunities at CSL